RESEARCHER PROFILE

Fernando Tomas Lanas

← Back to Universidad de La Frontera

F

Universidad de La Frontera

Cardiovascular Health and Risk FactorsBlood Pressure and Hypertension StudiesAcute Ischemic Stroke ManagementAtrial Fibrillation Management and OutcomesDiabetes, Cardiovascular Risks, and Lipoproteins

Fernando Tomas Lanas works in Cardiovascular Health and Risk Factors, Blood Pressure and Hypertension Studies, Acute Ischemic Stroke Management, Atrial Fibrillation Management and Outcomes, Diabetes, Cardiovascular Risks, and Lipoproteins. Recorded institutional associations include Universidad de La Frontera, Hospital Doctor Hernán Henríquez Aravena.

452Publications
53,399Citations
89H-index

Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.

Selected research works

Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.

  1. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study

    2004 · 12,018 citations
  2. Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

    2019 · 3,129 citations
  3. Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease

    2017 · 2,436 citations
  4. Apixaban in Patients with Atrial Fibrillation

    2011 · 2,433 citations
  5. Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study

    2016 · 2,284 citations
  6. Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study

    2019 · 2,000 citations
  7. Associations of fats and carbohydrate intake with cardiovascular disease and mortality in 18 countries from five continents (PURE): a prospective cohort study

    2017 · 1,101 citations
  8. Cardiovascular Risk and Events in 17 Low-, Middle-, and High-Income Countries

    2014 · 981 citations
  9. Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey

    2011 · 966 citations
  10. Urinary Sodium and Potassium Excretion, Mortality, and Cardiovascular Events

    2014 · 887 citations
  11. Association of Urinary Sodium and Potassium Excretion with Blood Pressure

    2014 · 858 citations
  12. Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial

    2017 · 754 citations
  13. Variations in common diseases, hospital admissions, and deaths in middle-aged adults in 21 countries from five continents (PURE): a prospective cohort study

    2019 · 651 citations
  14. Fruit, vegetable, and legume intake, and cardiovascular disease and deaths in 18 countries (PURE): a prospective cohort study

    2017 · 646 citations
  15. Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

    2019 · 633 citations
  16. Socioeconomic status and risk of cardiovascular disease in 20 low-income, middle-income, and high-income countries: the Prospective Urban Rural Epidemiologic (PURE) study

    2019 · 618 citations
  17. Efficacy of apixaban when compared with warfarin in relation to renal function in patients with atrial fibrillation: insights from the ARISTOTLE trial

    2012 · 573 citations
  18. Dronedarone in High-Risk Permanent Atrial Fibrillation

    2011 · 544 citations
  19. Associations of urinary sodium excretion with cardiovascular events in individuals with and without hypertension: a pooled analysis of data from four studies

    2016 · 484 citations
  20. Safety of Proton Pump Inhibitors Based on a Large, Multi-Year, Randomized Trial of Patients Receiving Rivaroxaban or Aspirin

    2019 · 483 citations
  21. Five-Year Outcomes after Off-Pump or On-Pump Coronary-Artery Bypass Grafting

    2016 · 432 citations
  22. Association of dairy intake with cardiovascular disease and mortality in 21 countries from five continents (PURE): a prospective cohort study

    2018 · 429 citations
  23. Global mortality variations in patients with heart failure: results from the International Congestive Heart Failure (INTER-CHF) prospective cohort study

    2017 · 409 citations
  24. Availability and affordability of cardiovascular disease medicines and their effect on use in high-income, middle-income, and low-income countries: an analysis of the PURE study data

    2015 · 392 citations
  25. Association of the triglyceride glucose index as a measure of insulin resistance with mortality and cardiovascular disease in populations from five continents (PURE study): a prospective cohort study

    2022 · 386 citations

← Return to the university profile